Comments
-
What are we really missing out on?
- Wed Jul 22
Medicines Australia’s new report contains a list of medicines it claims Australia should fund, but we found a number of therapies on the list hard to justify.
Read more -
Move over Big Pharma, media has a new villain
- Mon Jul 20
The Australian media has been unusually kind to pharma of late. Unfortunately for the TGA and medtech, Nine media have found a new target.
Read more -
Guild gets by with a little help from a friend
- Wed Jul 15
The high-profile spokesperson for a patient organisation housed in the same premises opposes a controversial proposal to allow prescription meds in supermarkets.
Read more -
Butler leans on PBAC to help dodge MFN risk
- Fri Jul 3
As PBAC considers whether two MS treatments are essential or expendable, Minister Butler can’t avoid the fact this decision ultimately lies with him.
Read more -
The truth behind our ‘world‑class’ PBS
- Mon Jun 29
We’re told we have one of the world’s best healthcare systems, writes Pfizer ANZ MD Ben Fitsimmons for MedNews, adding here’s what we’re not being told.
Read more -
Butler’s PBS spin falls short of reality
- Mon Jun 29
Health Minister can’t even get the details right as he struggles to justify stewardship of a scheme he has virtually ignored for four years.
Read more -
How China is reshaping global pharma strategy
- Wed Jun 24
The world is changing rapidly. Who Australia relies on for medicines in this global game of snakes and ladders is becoming a crucial question.
Read more -
Hold the front page! PBS in strife!
- Mon Jun 22
Mainstream media has finally woken to the fact Australia’s access to medicines is in serious danger, but can the situation be salvaged or is it already too late?
Read more -
In the world of MFN, is HTA facing irrelevance?
- Fri Jun 12
Despite multiple geopolitical threats, HTA agencies are pushing on, but are forces already in play that will make their efforts redundant?
Read more -
Leaders raise alarm over shrinking sectors
- Fri Jun 5
Industry leaders and patients are crying out for the government to rescue Australia’s dying medicines sector, but their cries are falling on deaf ears.
Read more